Meet Us at DDIP Europe 2026 in Basel
Isogenica will attend the Drug Discovery Innovation Programme Europe, taking place in Basel on 29–30 September 2026. DDIP Europe brings together senior drug discovery leaders from pharma, biotech and translational science for focused discussion around emerging technologies, biologics, computational approaches and novel therapeutic modalities.
Visit The VHH Company™ at our stand to discuss how synthetic VHH antibody discovery can support programmes involving intracellular targets, difficult targets and advanced therapeutic formats. For discovery teams working around complex biology, our platforms are designed to accelerate lead selection, reduce early-stage risk and generate developable VHH antibodies for downstream engineering.